Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance-Reference-Cited by-同舟云学术

Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance

Published:2020-01-24 Issue:4 Volume:147 Page:1117-1130
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Rozga Piotr¹^ORCID,Kloska Damian²^ORCID,Pawlak Sebastian¹,Teska‐Kaminska Malgorzata¹,Galazka Marlena¹,Bukato Katarzyna¹,Pieczykolan Anna¹,Jaworski Albert¹,Molga‐Kaczmarska Anna¹,Kopacz Aleksandra²^ORCID,Badyra Bogna²^ORCID,Kachamakova‐Trojanowska Neli²^ORCID,Zolnierkiewicz Olga²,Targosz‐Korecka Marta³^ORCID,Poleszak Katarzyna¹,Szymanik Michal¹,Zerek Bartlomiej¹,Pieczykolan Jerzy¹,Jozkowicz Alicja²^ORCID,Grochot‐Przeczek Anna²^ORCID

Affiliation:

1. Department of Drug DiscoveryAdamed Pharma S.A. Pienkow Czosnow Poland

2. Department of Medical BiotechnologyFaculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University Krakow Poland

3. Department of Physics of Nanostructures and NanotechnologyInstitute of Physics, Jagiellonian University Krakow Poland

Funder

National Centre for Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32845